Search results for

The International Association of Athletics Federations said that despite "good progress," Russia hasn't done enough to address a "deeply rooted culture of tolerance — or worse — for doping."

The U.S. has threatened sanctions following Russia's actions in Crimea, but European countries have been more circumspect. Part of the reason: Europe's dependence on Russian money and energy.

Panama's economy, while cooling in recent years, is still growing at astonishing rates compared to its neighbors. But environmental damage and huge government debt are part of the package.

Supporters of the Ukrainian president's arch rival are moving quickly to take government power; gawking protesters find opulence in the president's abandoned residence.

It's the end of the month, which means it's time for the best of the month, including new music from Kyle Hall, Tessela, Cassy and more.

The Justice Department and the intelligence community say reauthorizing the Foreign Intelligence Surveillance Amendments Act, which expires at the end of the year, is their top national security priority. But an interesting mix of senators are sounding alarms about whether the government is secretly gathering too much information on innocent Americans, and keeping it for far too long. They cite a newly declassified letter that exposes an incident where even the Obama administration acknowledges it went too far.

The Identity Theft Resource Center, which tracks hacks and data theft, says health care topped the list in the U.S. last year for cyberattacks.

The freshman Democratic House Rep. said conversations with constituents across Illinois' 17th Congressional District prompted him to issue a statement calling for President Joe Biden to end his bid for reelection in November.

A bot account sent mean notes to users who posted their Wordle score — and it also revealed the next day's answer. It was suspended for violating Twitter's rules.

Drugmakers make big profits in the U.S. But many pay taxes far below the 21% corporate tax rate. Pfizer's effective tax rate is so low it's getting a big refund despite booking $59 billion in revenue.